Application Of Echogenic Needles In High-BMI Obese Patient Difficult Anesthesia 1. Clinical Pain Points
Aug 13, 2026
https://www.nature.com/articles/s41598-024-72620-8
High-BMI obese patients have always been the key difficult group in regional nerve block anesthesia. A large amount of subcutaneous adipose tissue leads to deep nerve distribution position, and fat tissue has strong ultrasonic attenuation effect, resulting in serious blurring of target nerve ultrasound imaging. Ordinary puncture needles have weak ultrasonic reflection ability in high-fat tissues, fuzzy needle tip images and untrackable puncture trajectory, making real-time visual positioning impossible. Clinicians can only rely on empirical blind puncture, with extremely low positioning accuracy, high incomplete block rate and frequent intraoperative pain awakening. In addition, obese patients have dense overlapping of deep blood vessels and nerves, and blind puncture is easy to cause vascular injury, deep hematoma and nerve compression damage. Inaccurate positioning also leads to blind increase of local anesthetic dosage, significantly increasing the risk of drug poisoning and cardiovascular adverse reactions, bringing great safety hidden dangers to clinical anesthesia.
2. Product Anti-Interference Working Principle
Echogenic Needle for Nerve Block solves the difficult anesthesia problem of high-BMI patients through enhanced echo anti-attenuation technology and dual anti-interference positioning system. The upgraded laser precision marking process forms dense ultrasonic reflection structures on the stainless steel needle surface, which greatly improves the ultrasonic reflection intensity, effectively resists the signal attenuation interference of thick adipose tissues, and presents stable and clear high-brightness needle body images in deep high-fat layers. The high-sensitivity electrical nerve stimulation system has strong anti-fat interference ability, which can stably capture deep nerve bioelectrical signals and induce targeted muscle contraction feedback, realizing accurate needle tip positioning independent of ultrasound imaging quality. The dual-mode complementary mechanism of visual imaging and nerve electrical feedback completely overcomes the technical dilemma of invisible needle and difficult nerve positioning in obese patients' deep tissues.
3. Product Specification Classification for High-BMI Scenarios
Aiming at the anatomical characteristics of obese patients, echogenic needles are divided into enhanced anti-attenuation series specifications. The 16G-18G ultra-enhanced deep puncture specifications are suitable for severe obese patients with BMI>30, used for ultra-deep nerve block of hip, pelvic and deep lower limb nerves, with super strong echo anti-attenuation ability and stable imaging in thick fat layers. The 19G-20G long anti-attenuation specifications are suitable for moderate obese patients with BMI 25-30, adapting to routine deep nerve block of upper and lower limbs. All products adopt lengthened high-strength medical stainless steel design, which is not easy to bend and deform during ultra-deep puncture.经过 professional electropolishing and high-pressure sterilization treatment, they have stable physical and chemical properties, and support customized length and packaging to meet the personalized anesthesia needs of obese patients.
4. Standard Anti-Attenuation Puncture Operation Guidelines
Preoperatively evaluate the patient's BMI index, subcutaneous fat thickness and target nerve depth, select enhanced anti-attenuation echogenic needle specifications. Adopt low-frequency deep tissue ultrasound probe, appropriately adjust ultrasound gain, depth and contrast parameters to optimize deep nerve imaging effect. Place the patient in a stable operative position, scan and mark the running track of deep target nerves and surrounding key vascular structures. Adopt slow and stable in-plane deep puncture technique, advance the lengthened needle uniformly, and monitor the needle entry trajectory in real time through enhanced echo images. Turn on the high-sensitivity nerve stimulation mode, fine-tune the needle position according to muscle contraction feedback until the optimal nerve proximity state is achieved. After negative pressure aspiration is negative, inject local anesthetic in quantitative batches, observe the full coverage of drugs on deep nerves, and complete the block operation.
5. Clinical Practical Application Effect
Clinical data verification shows that enhanced echogenic needles completely reverse the anesthesia dilemma of high-BMI patients. For severe obese patients with BMI>30, the deep nerve block success rate of ordinary needles is only 62%, while the application of anti-attenuation echogenic needles increases the success rate to 95%. The enhanced echo structure solves the core problem of invisible needle tip in fat layers, reducing puncture adjustment times by more than 70% and shortening anesthesia positioning time by half. The dual anti-interference positioning technology avoids blind puncture damage to deep blood vessels and nerves, reducing the incidence of postoperative hematoma and nerve injury complications by 68%. Accurate positioning avoids excessive drug dosage, effectively reduces the risk of local anesthetic poisoning in obese patients, and makes intraoperative anesthesia state more stable and safer.
6. Summary and Technical Sublimation
High-BMI obese patients have always been the difficult group of regional anesthesia due to the ultrasonic attenuation interference of adipose tissue and deep nerve location. Traditional ordinary needles and single ultrasound guidance technology are difficult to adapt to the deep tissue anesthesia needs of obese patients, with low accuracy and high safety risks. Echogenic nerve block needles rely on enhanced echo anti-attenuation technology and dual-mode anti-interference positioning system to break through the technical barriers of difficult anesthesia for special obese groups. It significantly improves the success rate, accuracy and safety of nerve block in high-BMI patients, fills the technical gap of difficult anesthesia for special groups, and improves the coverage and precision of modern clinical regional anesthesia.
7. Future Application Promotion Suggestions
With the increasing prevalence of obesity, the number of high-BMI surgical patients continues to grow, and the demand for difficult precision anesthesia technology is rising year by year. It is suggested that tertiary hospitals take difficult anesthesia of obese patients as the key promotion direction of echogenic needle technology, and fully popularize enhanced anti-attenuation products. Formulate special operation specifications for obese patient nerve block, strengthen clinicians' training in deep anti-interference puncture and dual-mode positioning skills. Manufacturers should continuously optimize the deep echo enhancement process, develop ultra-deep special specifications for severe obese patients, and further improve the positioning accuracy of ultra-deep nerves. Accelerate the accumulation of clinical big data to form a standardized anesthesia technical system for special obese groups.







